Age-dependent rebound in asthma exacerbations after COVID-19 lockdown
- PMID: 36377231
- PMCID: PMC9364738
- DOI: 10.1016/j.jacig.2022.06.001
Age-dependent rebound in asthma exacerbations after COVID-19 lockdown
Abstract
Background: Virus mitigation measures enacted early in the coronavirus infectious disease 2019 (COVID-19) pandemic suppressed common respiratory viruses and reduced the number of obstructive lung disease exacerbations. However, many localities began to ease these precautions in the year 2021, leading to a resurgence of non-COVID viruses. How asthma and chronic obstructive pulmonary disease (COPD) activity responded to this upswing in viral abundance is unclear.
Objective: Our aim was to examine how viral resurgence during the relaxation of COVID-19 restrictions affected asthma and COPD exacerbations.
Methods: We analyzed electronic medical records for emergency department (ED) respiratory virus positivity, asthma visits, and COPD visits. We compared the 52-week interval before the COVID-19 restrictions (the pre-lockdown period [March 22, 2019-March 19, 2020]), the 52-week period immediately following enactment of the restrictions (the lockdown period [March 20, 2020-March 18, 2021]), and the 52-week period thereafter (the post-lockdown period [March 19, 2021-March 18, 2022]). We used MetaCYCLE to analyze seasonal trends in our data.
Results: The post-lockdown period was marked by a 400% increase in viral positivity compared with during the lockdown period. Asthma- and COPD-related ED visits each rose 37% compared with during the lockdown, with the rebound in asthma ED visits concentrated in individuals younger than 20 years. Interestingly, after the lockdown period, asthma ED visits overcorrected in children younger than 5 years, rising 81% compared with before the lockdown. Seasonal rhythms in asthma and COPD exacerbations were suppressed during the lockdown and recovered after the lockdown.
Conclusions: COVID-19 precautions had the unexpected effect of magnifying early-childhood asthma activity once common respiratory viruses recurred. These results may have implications for the future use of virus mitigation strategies in young children.
Keywords: Asthma; COPD; COPD, Chronic obstructive pulmonary disease; COVID-19; COVID-19, Coronavirus disease 2019; ED, Emergency department; RV, Rhinovirus; lockdown; respiratory viruses.
© 2022 The Author(s).
Figures



Similar articles
-
Effect of the COVID-19 Lockdown on Asthma Biological Rhythms.J Biol Rhythms. 2022 Apr;37(2):152-163. doi: 10.1177/07487304221081730. Epub 2022 Mar 23. J Biol Rhythms. 2022. PMID: 35319293 Free PMC article.
-
Examining the effect of the COVID-19 pandemic on community virus prevalence and healthcare utilisation reveals that peaks in asthma, COPD and respiratory tract infection occur with the re-emergence of rhino/enterovirus.Thorax. 2023 Dec;78(12):1248-1253. doi: 10.1136/thorax-2022-219957. Epub 2023 Jul 9. Thorax. 2023. PMID: 37423763 Free PMC article.
-
The effect of the COVID-19 lockdown on children with asthma-related symptoms: A tertiary care center experience.Pediatr Pulmonol. 2021 Sep;56(9):2825-2832. doi: 10.1002/ppul.25505. Epub 2021 Jun 14. Pediatr Pulmonol. 2021. PMID: 34126003 Free PMC article.
-
Targeting intercellular adhesion molecule-1 (ICAM-1) to reduce rhinovirus-induced acute exacerbations in chronic respiratory diseases.Inflammopharmacology. 2022 Jun;30(3):725-735. doi: 10.1007/s10787-022-00968-2. Epub 2022 Mar 22. Inflammopharmacology. 2022. PMID: 35316427 Free PMC article. Review.
-
The similarities and differences of epidemic cycles of chronic obstructive pulmonary disease and asthma exacerbations.Proc Am Thorac Soc. 2007 Dec;4(8):591-6. doi: 10.1513/pats.200706-064TH. Proc Am Thorac Soc. 2007. PMID: 18073388 Review.
Cited by
-
The Interplay Between Respiratory Syncytial Virus and Asthma Inception: Insights Gained From the COVID-19 Pandemic.Pediatr Pulmonol. 2025 Jan;60(1):e27474. doi: 10.1002/ppul.27474. Epub 2025 Jan 6. Pediatr Pulmonol. 2025. PMID: 39760467 Free PMC article.
-
Prolonged School Closure and Pediatric Respiratory Hospitalization: The Silver Lining of the COVID-19 Pandemic.Glob Pediatr Health. 2024 Jan 31;11:2333794X231224999. doi: 10.1177/2333794X231224999. eCollection 2024. Glob Pediatr Health. 2024. PMID: 38303757 Free PMC article.
-
Effects of seasonality and treatment on COPD clinical outcomes: IMPACT post hoc analysis.ERJ Open Res. 2025 Feb 25;11(1):00583-2024. doi: 10.1183/23120541.00583-2024. eCollection 2025 Jan. ERJ Open Res. 2025. PMID: 40008169 Free PMC article.
-
Modifiable risk factors for asthma exacerbations during the COVID-19 pandemic: a population-based repeated cross-sectional study using the Research and Surveillance Centre primary care database.Lancet Reg Health Eur. 2024 May 24;42:100938. doi: 10.1016/j.lanepe.2024.100938. eCollection 2024 Jul. Lancet Reg Health Eur. 2024. PMID: 38846423 Free PMC article.
-
Asthma exacerbations during the pandemic: Time to rethink clinical markers.J Allergy Clin Immunol Glob. 2023 Feb;2(1):97-100. doi: 10.1016/j.jacig.2022.09.003. Epub 2022 Oct 20. J Allergy Clin Immunol Glob. 2023. PMID: 36281240 Free PMC article.
References
-
- Kuitunen I., Artama M., Makela L., Backman K., Heiskanen-Kosma T., Renko M. Effect of social distancing due to the COVID-19 pandemic on the incidence of viral respiratory tract infections in children in Finland during early 2020. Pediatr Infect Dis J. 2020;39:e423–e427. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources